Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
作者信息
Lamarca Angela, Palmer Daniel H, Wasan Harpreet Singh, Ross Paul J, Ma Yuk Ting, Arora Arvind, Falk Stephen, Gillmore Roopinder, Wadsley Jonathan, Patel Kinnari, Anthoney Alan, Maraveyas Anthony, Iveson Tim, Waters Justin S, Hobbs Claire, Barber Safia, Ryder W David, Ramage John, Davies Linda M, Bridgewater John A, Valle Juan W
机构信息
Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK.
University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK.
出版信息
Lancet Oncol. 2021 Jul;22(7):e288-e289. doi: 10.1016/S1470-2045(21)00341-7.
Abstract
摘要
相似文献
1
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.晚期胆管癌的二线FOLFOX化疗——作者回复
Lancet Oncol. 2021 Jul;22(7):e288-e289. doi: 10.1016/S1470-2045(21)00341-7.
2
Second-line FOLFOX chemotherapy for advanced biliary tract cancer.晚期胆管癌的二线FOLFOX化疗
Lancet Oncol. 2021 Jul;22(7):e287. doi: 10.1016/S1470-2045(21)00280-1.
3
Second-line FOLFOX chemotherapy for advanced biliary tract cancer.晚期胆管癌的二线FOLFOX化疗
Lancet Oncol. 2021 Jul;22(7):e286. doi: 10.1016/S1470-2045(21)00269-2.
4
Second-line FOLFOX chemotherapy for advanced biliary tract cancer.晚期胆管癌的二线FOLFOX化疗
Lancet Oncol. 2021 Jul;22(7):e285. doi: 10.1016/S1470-2045(21)00243-6.
5
Second-line FOLFOX chemotherapy for advanced biliary tract cancer.晚期胆管癌的二线FOLFOX化疗
Lancet Oncol. 2021 Jul;22(7):e284. doi: 10.1016/S1470-2045(21)00211-4.
6
Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology.二线FOLFOX并非所有晚期胆管癌患者的标准治疗方案——来自国际老年肿瘤学会青年部的评论
Ann Oncol. 2023 Jun;34(6):555-556. doi: 10.1016/j.annonc.2023.02.007. Epub 2023 Feb 21.
7
Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.5-氟尿嘧啶和亚叶酸在治疗胰胆管腺癌中的作用。
Am J Clin Oncol. 2000 Aug;23(4):425-8. doi: 10.1097/00000421-200008000-00023.
8
Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care?晚期胆管癌的二线氟嘧啶类双联化疗：一种新的治疗标准？
Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):201-203. doi: 10.1080/17474124.2022.2047652. Epub 2022 Mar 2.
9
Response to letter to the editor: Use, response and outcomes of second line chemotherapy in patients with advanced biliary tract cancers.对编辑来信的回复：晚期胆管癌患者二线化疗的使用、反应及结果
J Oncol Pharm Pract. 2023 Jun;29(4):1027. doi: 10.1177/10781552231165698. Epub 2023 Mar 27.
10
How we treat advanced biliary tract cancers in the second-line setting.我们如何在二线治疗中治疗晚期胆管癌。
Clin Adv Hematol Oncol. 2023 Jan;21(1):35-42.
引用本文的文献
1
Long-Term Outcomes of 5-Fluorouracil-Related Early-Onset Toxicities: A Retrospective Cohort Study.5-氟尿嘧啶相关早发性毒性的长期结局：一项回顾性队列研究
Cancers (Basel). 2024 Dec 3;16(23):4050. doi: 10.3390/cancers16234050.
2
Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis.使用AVB-500可溶性受体靶向AXL并通过基因敲低抑制胆管癌的生长和转移。
Cancers (Basel). 2023 Mar 21;15(6):1882. doi: 10.3390/cancers15061882.
Zotero 插件